If you have a little time why not drop by the Open Targets website and give the beta test version and give them some feedback. Full details are in the blog post.

The beta version makes the most of the data from the recent 21.02 release and you can also interrogate the data using the brand new GraphQL API.

In particular, this version features:

• Redesigned evidence pages
• Updated drug profile pages
• More complete disease profile pages

Open Targets is a public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation. The current focus is on oncology, immunology and neurodegeneration.

Generating and interpreting the data required to identify a good drug target demands a diverse set of skills, backgrounds, evidence types and technologies, which do not exist today in any single entity. Open Targets brings together expertise from seven complementary institutions to systematically identify and prioritise targets from which safe and effective medicines can be developed.